Latest Safety News

Actinogen Medical has published a peer-reviewed article confirming the efficacy of a 10 mg daily dose of Xanamem for treating neurological conditions, reinforcing its ongoing clinical trials in Alzheimer's and depression.

Lindian Resources has awarded a $1.3 million contract to Mota-Engil for the construction of a critical access road at its Kangankunde Rare Earths Project in Malawi, marking a key milestone in project development and local infrastructure enhancement.

WA Kaolin Limited has announced a fully underwritten pro-rata accelerated non-renounceable rights offer to raise approximately $7 million, aiming to bolster working capital and support production ramp-up at its Wickepin operations.

WA Kaolin Ltd has launched a fully underwritten A$7 million entitlement offer to fund a critical ramp-up in production following successful operational upgrades. With strong forward orders and supportive major shareholders, the company aims to achieve positive cash flow and expand its market footprint.

WA Kaolin Limited is raising A$7 million through a fully underwritten entitlement offer to support its sales ramp-up and working capital needs, following a successful upgrade to its classifier project that enhances production capabilities.

AdAlta has fast-tracked its cellular immunotherapy growth by signing two new term sheets for clinical-stage CAR-T products from Asia, pivoting to focus on in-licensing and clinical trials while winding down internal R&D on its antifibrotic drug AD-214.

Beach Energy has reported a robust first half of FY25, marked by a 37% increase in underlying earnings and significant progress on key projects including the Waitsia Gas Plant commissioning and Moomba CCS. The company’s strong operational performance supports a 50% increase in its interim dividend.

Beach Energy has reported a robust 15% increase in production and a 37% rise in underlying NPAT for the first half of FY25, underpinned by operational improvements and strategic initiatives. The company also announced a 50% increase in its interim dividend, signaling strong confidence in its financial outlook.

A new peer-reviewed study highlights Cynata Therapeutics’ Cymerus™ iPSC-derived MSCs as superior to traditional donor tissue-derived MSCs in potency, consistency, and regenerative potential.

Macro Metals Limited has launched its second Indigenous joint venture, Robe River Kuruma Macro Mining, to foster sustainable mining and socio-economic benefits in the West Pilbara region.

Dynamic Metals has secured approval to commence an extensive Reverse Circulation drilling campaign at its Cognac West gold prospect, targeting high-grade anomalies identified in recent sampling. The program, set to begin in early 2025, aims to unlock significant gold mineralisation in Western Australia’s Widgiemooltha region.

Bio-Gene Technology Limited has secured A$3 million in U.S. Department of Defense grants to accelerate development of its two nature-derived insecticides, Flavocide and Qcide, targeting both military and civilian markets.